Q32 Bio
QTTB
92 hedge funds and large institutions have $37.8M invested in Q32 Bio in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 21 closing their positions.
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
90% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 21
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
26% more funds holding
Funds holding: 73 → 92 (+19)
14.75% more ownership
Funds ownership: 75.53% → 90.27% (+15%)
88% less call options, than puts
Call options by funds: $62K | Put options by funds: $498K
91% less capital invested
Capital invested by funds: $406M → $37.8M (-$368M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$22M |
| 2 |
MAM
Monaco Asset Management
Monaco
|
+$18.2M |
| 3 |
Mariner
Overland Park,
Kansas
|
+$3.83M |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$3.07M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$18M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.9M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.48M |
| 4 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$7.27M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.77M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Jane Street
New York
| – | -$733K | -16,437 | Closed |
|
102
Renaissance Technologies
New York
| – | -$721K | -16,164 | Closed |
|
|
UOC
103
UBS O'Connor
Chicago,
Illinois
| – | -$590K | -13,229 | Closed |
|
|
EI
104
EAM Investors
Solana Beach,
California
| – | -$567K | -12,703 | Closed |
|
|
TI
105
Trexquant Investment
Stamford,
Connecticut
| – | -$348K | -7,790 | Closed |
|
106
Franklin Resources
San Mateo,
California
| – | -$225K | -4,857 | Closed |
|
|
AGP
107
Artia Global Partners
Miami,
Florida
| – | -$210K | -4,705 | Closed |
|
|
MIM
108
MetLife Investment Management
Whippany,
New Jersey
| – | -$159K | -3,563 | Closed |
|
|
VFA
109
Values First Advisors
Gray,
Tennessee
| – | -$33K | -741 | Closed |
|
110
Allspring Global Investments
Charlotte,
North Carolina
| – | -$5.84K | -131 | Closed |
|
111
US Bancorp
Minneapolis,
Minnesota
| – | -$1.38K | -31 | Closed |
|
112
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$1.07K | -24 | Closed |
|
113
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$32 | -1 | -20% |
|
QTTB Hedge Fund Activity: Q4 2024 in Review
92 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2024, worth a combined $37.8M — down 91% from $406M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new QTTB positions and 21 closed out — a net gain of 19 holders — while 22 added to existing stakes and 10 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $22M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $18M sold.
- 92 institutional investors held Q32 Bio (QTTB) as of Q4 2024, up from 73 in Q3 2024.
- Funds reported $37.8M of Q32 Bio stock for Q4 2024, down 91% quarter-over-quarter.
- 40 funds opened new Q32 Bio positions in Q4 2024 and 21 closed out, a net change of +19 holders.
- The largest Q32 Bio buyer in Q4 2024 was Sio Capital Management, an estimated $22M added.
- The largest Q32 Bio seller in Q4 2024 was Adage Capital Partners, an estimated $18M sold.
Based on aggregated 13F filings for Q4 2024.